We are live on ! Find out more
FMS icon

Fresenius Medical Care

175 hedge funds and large institutions have $352M invested in Fresenius Medical Care in 2019 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 40 increasing their positions, 61 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 2.91%2.91% (+0%)

3% less capital invested

Capital invested by funds: $362M → $352M (-$10.8M)

4% less funds holding

Funds holding: 182175 (-7)

19% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 31

34% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 61

Holders
175
Holders Change
-7
Holders Change %
-3.85%
% of All Funds
3.8%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
25
Increased
40
Reduced
61
Closed
31
Calls
Puts
Net Calls
Net Calls Change

FMS Hedge Fund Activity: Q2 2019 in Review

175 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Fresenius Medical Care (FMS) for Q2 2019, worth a combined $352M — down 3% from $362M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of FMS and 25 opened new positions — a net loss of 6 holders — while 61 trimmed existing stakes and 40 added.

The largest buyer was Morgan Stanley, adding an estimated $25.5M. The largest seller was Renaissance Group, exiting entirely with an estimated $15.3M sold.

  • 175 institutional investors held Fresenius Medical Care (FMS) as of Q2 2019, down from 182 in Q1 2019.
  • Funds reported $352M of Fresenius Medical Care stock for Q2 2019, down 3% quarter-over-quarter.
  • 25 funds opened new Fresenius Medical Care positions in Q2 2019 and 31 closed out, a net change of -6 holders.
  • The largest Fresenius Medical Care buyer in Q2 2019 was Morgan Stanley, an estimated $25.5M added.
  • The largest Fresenius Medical Care seller in Q2 2019 was Renaissance Group, an estimated $15.3M sold.

Based on aggregated 13F filings for Q2 2019.